Science for Life.
ProPhase Labs develops and markets clinically proven remedies including the highly effective Cold-EEZE® and Kids-EEZE® product lines. Our ongoing objective is to deliver long-term value by providing exceptional new products that address the health care and quality of life concerns of the broadest market segments.
January 09, 2017 - ProPhase Labs Schedules an Investor Conference Call for Tuesday, January 10th at 4:30 PM
January 09, 2017 - PROPHASE LABS, INC. ANNOUNCES AGREEMENT TO SELL COLD-EEZE® BRAND
August 09, 2016 - ProPhase Labs Reports Financial Results for the Three Months and Six Months Ended June 30, 2016; Exploring Strategic Alternatives to Enhance Shareholder Value
The Cold-EEZE® family of lozenges are clinically proven to reduce the duration of the common cold.